하이드로겔 드레싱 시장 : 제품별, 재료별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global hydrogel dressing market size reached USD 475.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 721.9 Million by 2033, exhibiting a growth rate (CAGR) of 4.51% during 2025-2033.

Hydrogel dressings rehydrate necrotic and sloughy tissue to effect debridement while providing moisture to wounds. They comprise water suspended in a gel made up of insoluble hydrophilic polymers, which swell up on contact with water. They are manufactured from polymers of synthetic molecules, such as polymethacrylate and polyvinylpyrrolidone. They control the exchange of fluid at the wound-bandage interface, promote granulation, and encourage complete healing. They assist in alleviating pain while preventing dead space from becoming infected. In addition, they boost wound re-epithelialization as hydrogel dressings partially mimic skin structure and enhance the growth of skin components. As a result, they find extensive applications in hospitals, specialty clinics, and home healthcare centers across the globe.

Hydrogel Dressing Market Trends:

At present, the growing prevalence of chronic wounds, such as venous, pressure, and ischemic ulcers, represents one of the key factors driving the market. Besides this, governments of several countries are undertaking initiatives to increase awareness about the diagnosis and treatment of diabetic foot ulcers, which is contributing to the growth of the market. Moreover, key market players are extensively investing in research and development (R&D) activities to introduce cost-effective products for improving the treatment of chronic wounds. They are also focusing on marketing strategies to boost their sales. In addition, the growing utilization of hydrogel dressings to keep wounds clean by eliminating diseased or necrotic tissues via autolysis is offering a positive market outlook. Apart from this, the increasing demand for advanced wound care products to prevent surgical site infections is offering lucrative growth opportunities to industry investors. Additionally, there is a rise in the incidence of blood clotting in trauma cases around the world. This, along with the burgeoning healthcare industry, is bolstering the growth of the market.

Key Market Segmentation:

Breakup by Product:

• Amorphous Hydrogel
• Impregnated Hydrogel
• Sheet Hydrogel

Breakup by Material:

• Natural
• Synthetic
• Semi-synthetic

Breakup by Application:

• Diabetic Foot Ulcer
• Pressure Ulcer
• Venous Leg Ulcer
• Burn Wounds
• Others

Breakup by End User:

• Hospital
• Physician's Office
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Axelgaard Manufacturing Co Ltd, B Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), Convatec Group plc, Hollister Incorporated, Integra LifeSciences, Lohmann & Rauscher GmbH & Co. KG (Lohmann & Rauscher International GmbH & Co. KG), McKesson Corporation, Medline Industries LP, Procyon Corporation and Smith & Nephew plc.

Key Questions Answered in This Report

• 1.What was the size of the global hydrogel dressing market in 2024?
• 2.What is the expected growth rate of the global hydrogel dressing market during 2025-2033?
• 3.What are the key factors driving the global hydrogel dressing market?
• 4.What has been the impact of COVID-19 on the global hydrogel dressing market?
• 5.What is the breakup of the global hydrogel dressing market based on the product?
• 6.What is the breakup of the global hydrogel dressing market based on the material?
• 7.What is the breakup of the global hydrogel dressing market based on the application?
• 8.What is the breakup of the global hydrogel dressing market based on the end user?
• 9.What are the key regions in the global hydrogel dressing market?
• 10.Who are the key players/companies in the global hydrogel dressing market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Hydrogel Dressing Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Amorphous Hydrogel
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Impregnated Hydrogel
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Sheet Hydrogel
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Material

• 7.1 Natural
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Synthetic
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Semi-synthetic
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Diabetic Foot Ulcer
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Pressure Ulcer
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Venous Leg Ulcer
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Burn Wounds
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospital
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Physician's Office
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 3M Company
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Axelgaard Manufacturing Co Ltd
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 B Braun Melsungen AG(B. Braun Holding GmbH & Co. KG)
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 SWOT Analysis
  • 15.3.4 Convatec Group plc
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
  • 15.3.5 Hollister Incorporated
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 SWOT Analysis
  • 15.3.6 Integra LifeSciences
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Lohmann & Rauscher GmbH & Co. KG(Lohmann & Rauscher International GmbH & Co. KG)
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 SWOT Analysis
  • 15.3.8 McKesson Corporation
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Medline Industries LP
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 SWOT Analysis
  • 15.3.10 Procyon Corporation
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
  • 15.3.11 Smith & Nephew plc
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis